NYSE: HLTH 0.16 +0.01 +4.8% Volume: 200 July 15, 2019

Nobilis Announces Estimated Revenues for the 1st Quarter of 2015

April 09, 2015

HOUSTON, TX--(Marketwired - Apr 9, 2015) - Nobilis Health Corp. (TSX: NHC) announces, on a consolidated basis, that its estimated revenue for the three months ending March 31, 2015 is between $33 and $35 million, compared to the 2014 first quarter revenue of $12.1 million. Due to seasonality in the healthcare business Nobilis historically produces approximately 14% of its annual revenue in the first quarter.

In conjunction with its anticipated listing on the NYSE MKT exchange and to provide consistency with its US-based peer group, the Company has decided to cease issuing pre-release top line revenue figures.

About Nobilis Health Corp.

Nobilis utilizes innovative direct-to-patient marketing focused on a specified set of procedures that are performed at our centers by local physicians. We own and manage ambulatory and acute care facilities to deliver healthcare services. Nobilis owns and manages interests in ambulatory surgery centers in Houston, Dallas, and Scottsdale, Arizona. In addition, Nobilis owns one acute care hospital in Houston. Nobilis also owns and manages interests in two imaging centers and one urgent care clinic in Houston.

Forward-looking statements

This news release may contain forward-looking statements (within the meaning of applicable securities laws) and financial outlooks relating to the business of Nobilis Health Corp. (the "Company") and the environment in which it operates. Forward-looking statements are identified by words such as "believe", "anticipate", "expect", "intend", "plan", "will", "may" and other similar expressions and may discuss future expectations, contain projections of future results of operations or of financial condition, or state other forward-looking information. These statements are based on the Company's expectations, estimates, forecasts and projections and while the Company considers these to be reasonable based on information currently available, they may prove to be incorrect. They are not guarantees of future performance and involve risks and uncertainties that are difficult to control or predict. These risks and uncertainties are discussed in the Company's regulatory filings available on the Company's web site at www.NobilisHealth.com or at www.Sedar.com. There can be no assurance that forward-looking statements will prove to be accurate as actual outcomes and results may differ materially from those expressed in these forward-looking statements. Readers, therefore, should not place undue reliance on any such forward-looking statements. Further, a forward-looking statement speaks only as of the date on which such statement is made. Other than as required by law, the Company undertakes no obligation to publicly update any such statement or to reflect new information or the occurrence of future events or circumstances.